Alan B. Lancz & Associates, Inc. Sanofi Transaction History

Alan B. Lancz & Associates, Inc.

$98.1 Million
Q2 2025

A detailed history of Alan B. Lancz & Associates, Inc. transactions in Sanofi stock. As of the latest transaction made, Alan B. Lancz & Associates, Inc. holds 5,250 shares of SNY stock, worth $260,714. This represents 0.26% of its overall portfolio holdings.

Number of Shares

5,250

Previous 5,250 -0.0%

Holding current value

$260,714

Previous $291,000 13.06%

% of portfolio

0.26%

Previous 0.31%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	SELL	$45.89 - $57.31 $36,712 - $45,848	-800 Reduced 13.22%	5,250 $253,000
Q3 2024 Nov 04, 2024	SELL	$48.54 - $58.53 $12,135 - $14,632	-250 Reduced 3.97%	6,050 $348,000
Q2 2024 Jul 24, 2024	SELL	$45.39 - $50.36 $9,531 - $10,575	-210 Reduced 3.23%	6,300 $305,000
Q4 2023 Feb 06, 2024	SELL	$43.13 - $54.79 $7,547 - $9,588	-175 Reduced 2.62%	6,510 $323,000
Q3 2023 Nov 13, 2023	SELL	$50.95 - $55.2 $14,775 - $16,008	-290 Reduced 4.16%	6,685 $358,000
Q1 2023 May 05, 2023	BUY	$45.86 - $54.45 $458 - $544	10 Added 0.14%	6,975 $379,000
Q4 2022 Feb 13, 2023	SELL	$38.86 - $48.55 $15,544 - $19,420	-400 Reduced 5.43%	6,965 $337,000
Q2 2022 Aug 11, 2022	SELL	$48.99 - $57.46 $19,596 - $22,984	-400 Reduced 5.15%	7,365 $366,000
Q4 2021 Apr 13, 2022	SELL	$47.07 - $52.35 $2.02 Million - $2.25 Million	-43,000 Reduced 84.7%	7,765 $389,000
Q4 2021 Feb 09, 2022	BUY	$47.07 - $52.35 $2.39 Million - $2.66 Million	50,765 New	50,765 $2.54 Million

Others Institutions Holding SNY

# of Institutions

828

Shares Held

260M

Call Options Held

1.75M

Put Options Held

1.6M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $125B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alan B. Lancz & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Alan B. Lancz & Associates, Inc. with notifications on news.

Account

Alan B. Lancz & Associates, Inc. Sanofi Transaction History